<DOC>
	<DOCNO>NCT01617980</DOCNO>
	<brief_summary>Radiotherapy , preferably combine chemotherapy , treatment standard locally advance , unresectable non-small cell lung cancer ( NSCLC ) . The tumor response different therapy protocol variable , hypoxia know major factor negatively influence treatment effectiveness . Visualisation tumor hypoxia prior use modern radiation therapy strategy , intensity modulate radiation therapy ( IMRT ) , might allow high dose application target volume , lead improvement therapy outcome . 18F-fluoromisonidazole dynamic positron emission tomography compute tomography ( 18F-FMISO dPET-CT ) functional magnetic resonance imaging ( functional MRI ) attractive strategy image tumor hypoxia . The HIL trial single centre pilot study combine multimodal hypoxia image 18F-FMISO dPET-CT functional MRI intensity modulate radiation therapy ( IMRT ) patient inoperable stage III NSCLC . 15 patient recruit study . All patient undergo serial 18F-FMISO dPET-CT functional MRI treatment , week 5 radiotherapy 6 week post treatment . Radiation therapy perform inversely plan IMRT four dimensional compute tomography ( 4D-CT ) base target volume definition . Hypoxia image include target volume definition IMRT dose prescription . Objectives trial characterize correlation 18F-FMISO dPET-CT functional MRI tumor hypoxia image NSCLC evaluate possible effect radiation therapy tumor re-oxygenation . Further objective include generation data regard prognostic value 18F-FMISO dPET-CT functional MRI locoregional control , progression free survival overall survival NSCLC treat IMRT , form basis large clinical trial focus possible interaction tumor oxygenation radiation outcome .</brief_summary>
	<brief_title>Multimodal Hypoxia Imaging Intensity Modulated Radiotherapy Inoperable Non-small-cell Lung Cancer</brief_title>
	<detailed_description>The HIL-trial design study initiator Clinical Cooperation Unit Radiation Oncology German Cancer Research Center ( DKFZ ) , Clinical Cooperation Unit Nuclear Medicine DKFZ , Department Radiology DKFZ Department Radiation Oncology University Clinic Heidelberg . The trial carry DKFZ co-operation Department Radiation Oncology University Clinic Heidelberg . Aim study characterize correlation 18F-FMISO dPET-CT functional MRI tumor hypoxia image patient stage III NSCLC , treat intensity modulate radiotherapy ( IMRT ) evaluate change tumor oxygenation radiation treatment . Objectives include evaluation prognostic value multimodal hypoxia image locoregional control , progression free survival overall survival patient NSCLC treat IMRT . The study design single centre pilot trial accrual 15 patient inoperable stage III NSCLC . Patients fulfil inclusion criterion treat intensity modulate radiation therapy ( IMRT ) . All patient undergo serial 18F-FMISO dPET-CT functional MRI treatment , week 5 radiotherapy 6 week post treatment . Eligible patient informed participation trial possible benefit risk , write informed consent obtain . Staging complete performance thoracic CT scan , abdominal ultrasound 18F-FDG dPET-CT scan . After immobilization vacuum mattress contrast-enhanced thoracic CT scan include four dimensional respiratory trigger carry . CT data synchronize recorded respiratory signal four-dimensional reconstruction perform evaluate motion thoracic organ tumor breathe cycle . Based 4D-CT data set , radiation treatment plan carry inverse planning . Radiation therapy perform intensity modulate radiation therapy ( IMRT ) . A dose 50-54 Gy apply primary tumor mediastinal lymph node daily fraction 5 × 2 Gy . Subsequently , primary tumor involve lymph node boost total dose 60-72 Gy daily fraction 5 × 2 Gy . Tolerance dose thoracic organ risk exceed . Treatment carry out-patient basis unless condition patient require hospital administration . 18F-FMISO provided Iason ( Graz , Austria ) . 18F-FMISO dPET-CT investigation perform prior radiotherapy , week 5 radiation therapy 6 week post treatment . dPET-CT examination perform i.v . injection 18F-FMISO use Biograph mCT S128 ( Siemens Medical Solutions Co. , Erlangen , Germany ) . The dynamic study acquire 28-frame protocol one hour . Quantification perform follow iterative reconstruction dPET-CT data use dedicated software package . Generally , volumes-of-interest ( VOIs ) place tumor reference region , follow compartment non-compartment analysis . A two-tissue compartment model model choice five parameter obtain . The quantification include calculation fractional blood volume , also name vessel density ( VB ) , parameter k1 k2 , reflect influx efflux FMISO cell , k3 k4 , related trap re-oxygenation FMISO . For input function mean value VOI data obtain large arterial vessel like descend aorta use . Besides VOI base analysis , parametric image calculate assess dedicate parameter FMISO kinetics . Besides compartment analysis non-compartment model base fractal dimension use . The fractal dimension ( FD ) parameter heterogeneity calculate time activity data individual VOI . The value fractal dimension vary 0 2 show deterministic chaotic distribution tracer activity . We use subdivision 7x7 maximal SUV 20 calculation FD . Functional MRI investigation perform prior radiation therapy , week 5 radiation therapy 6 week post treatment . All examination perform use clinical 1.5-T MRI scanner ( Magnetom Avanto , Siemens Medical Solutions , Erlangen , Germany ) . The standard protocol comprise coronal transversal breath-hold TrueFISP , T2w single-shot half-Fourier TSE ( HASTE ) T1w 3D-GRE ( VIBE ) sequence . Afterwards , navigator trigger transversal T2w-FatSat sequence ( T2-FS BLADE ) perform . Diffusion weight image perform use axial single shot echoplanar ( EPI ) sequence without flow-compensation . A total ten b-values ( 0 , 10 , 25 , 50 , 100 , 200 , 300 , 400 , 500 800 s/mm2 ) acquire enable extraction diffusion perfusion parameter . DWI parameter evaluate base Intravoxel Incoherent motion ( IVIM ) model , yield parameter perfusion fraction f diffusion constant D , use house develop open-source software MITK Diffusion , Version 2011 ( downloadable www.mitk.org ) . The parameter estimation base assumption diffusion measurement influence mainly two effect , perfusion related effect introduce molecule move capillary network ( pseudodiffusion coefficient , D* ) extravascular effect passive diffusion ( D ) . Since simultaneous nonlinear fit parameter D , D* , weight coefficient f instable , measurement b-values great 200 s/mm² use first step estimate f D describe . D* calculate second step use exhaustive search . Lung cancer perfusion assess use spoil 3D gradient echo sequence bolus injection 0.07 mmol/kg body weight Gd-DTPA . Ten acquisition one expiratory breath hold ( 10 x 2.25 = 22 ) follow 50 navigator-triggered acquisition free breathing . After co-registration 3D data set , ROI-based visualization signal-time curve perform . Furthermore , time-resolved echoshared gradient echo sequence ( TWIST ) perform assessment three-dimensional tumor motion ( 240 x 0.5s = TA 2 min ) . A dynamic 2D-TrueFISP sequence acquire coronal orientation cross centre tumor provide additional information lung tumor motion breathe cycle . Contrast-enhanced sequence breath hold 3D-GRE sequence ( VIBE ) complete protocol . The first follow-up plan 6 week post treatment include study-related 18F-FMISO dPET-CT functional MRI examination . Further regular follow-up visit schedule every 3 month first 2 year , every 6 month follow 3 year thereafter yearly . Individual trial participation complete three year patient enrolment death patient . The therapeutic efficacy evaluate thoracic CT-scan follow visit . The study prospective non-randomized trial inclusion 15 patient . Repeated examination 18F-FMISO dPET-CT functional MRI lead longitudinal data every patient . The data consist map obtain measurement device . Data quantitative measurement may dichotomize categorize two class . For parameter , difference site local relapse select control region derive compaired paired test 5 % level . All analyse exploratory . A sample size calculation perform neither standard deviation difference estimate , relevant difference know . Therefore , study pilot study generate hypotheses future research . In frame radiation therapy planning study , virtual radiation therapy strategy compare radiation therapy administer patient .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Documented inoperable , histologically confirm NSCLC stage III Sufficient remain lung function ( FeV1 &gt; 1.5 l/s least 50 % respective individual norm value ) Karnofsky Performance Score 70 % high . Patients &gt; 18 year age . Adequate haematological function ( wbc &gt; 3000 x 10^3 /ml , thc &gt; 100 ×10^6 /ml , Hb &gt; 10 g/dl ) Adequate hepatic renal function Written inform consent Patient refusal Severe concurrent systemic disease Claustrophobia Cardiac pacemaker Other malignancy Hypersensitivity xray contrast medium 18FFMISO Severe renal hepatic insufficiency NSCLC stage I , II IV Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Hypoxia imaging</keyword>
	<keyword>FMISO-PET</keyword>
	<keyword>functional MRI</keyword>
	<keyword>Intensity modulate radiation therapy</keyword>
</DOC>